T-cell mediated immunity against Aspergillus fumigatus

Completed

• Conditions: Aspergillosis; fungal infection; 10001708; 10017528

• Registration Number: NL-OMON35724
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Trial is onging in other countries

Detailed Description

Not available

Study Timeline

• Study Completion: 2015-11-02
• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 9

Inclusion Criteria

Diagnosis Invasive Aspergillosis or suspected for this diagnosis
Diagnosis allergic reaction to Aspergillus
Partner of patient with allergic reaction to Aspergillus

Exclusion Criteria

< 18 year of age
Not able to get informed consent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Frequency and cytokineprofile of Aspergillus-specific T-cells in blood and<br /><br>broncho-alveolar lavage fluid<br /><br>Presence and type of Aspergillus-specific antibodies</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>nvt</p><br>